scholarly journals Abnormalities of Megakaryocytes in Sl/Sld Mice

Blood ◽  
1973 ◽  
Vol 42 (6) ◽  
pp. 865-871 ◽  
Author(s):  
Shirley Ebbe ◽  
Elizabeth Phalen ◽  
Frederick Stohlman

Abstract Megakaryocytopoiesis was evaluated in Sl/Sld mice and their heterozygous and homozygous normal (+/+) littermates. Sl/Sld mice had a normal concentration of blood platelets which were of normal size. Numbers of megakaryocytes in bone marrow and spleen were reduced, but individual megakaryocytes were larger than normal.

2006 ◽  
Vol 45 (3) ◽  
pp. e120-e121
Author(s):  
Lukasz Partyka ◽  
Joanna Grzybowska ◽  
Urszula Czech ◽  
Anna Polus ◽  
Lukasz Wator ◽  
...  

Blood ◽  
1949 ◽  
Vol 4 (8) ◽  
pp. 936-946 ◽  
Author(s):  
ELIJAH ADAMS

Abstract Observations were made to investigate possible endocrine influences on blood platelets. Adrenal cortex extract failed to influence the platelet counts of mice, rats, or rabbits. Adrenalectomy and sham-adrenalectomy were followed by almost identical platelet increases in mice and rats. Administration of adrenal cortex extract, or physiologic saline, to adrenalectomized rats was followed by a consistent fall in platelets not observed in sham-adrenalectomized rats, or after administering distilled water to adrenalectomized rats. Platelet levels in hypophysectomized rats were significantly lower than in unoperated controls. Splenectomy in hypophysectomized rats was followed by a maximum rise in platelets markedly lower than following splenectomy in intact rats. Bone-marrow megakaryocytes in hypophysectomized rats were significantly fewer than in intact rats. No changes in megakaryocyte number or morphology appeared following splenectomy either in intact or hypophysectomized rats.


1960 ◽  
Vol 8 (1) ◽  
pp. 61-67 ◽  
Author(s):  
G. Adolph Ackerman

Endogenous and succinic dehydrogenase activity was demonstrated in the living cells of normal human blood and bone marrow using a buffered nitro BT-succinate incubating solution. With this technique dehydrogenase activity was localized primarily in the granular leukocytes and the sites of enzymatic activity appeared to be non-mitochondrial. The addition of a non-ionic surface active agent to the incubating solution resulted in marked differences in the cellular and intracellular localization of dehydrogenase activity. With this method it was possible to demonstrate dehydrogenase activity in the mitochondria of most of the formed elements of the blood and bone marrow, including developing granulocytes and erythroid cells, agranulocytes, and blood platelets. Mature erythrocytes also exhibited a minimal dehydrogenase reaction with this procedure. This investigation indicated that in order adequately to demonstrate and evaluate dehydrogenase activity in the cells of the blood and bone marrow it was necessary to have increased cellular and mitochondrial permeability, as well as partially viable cells with an intact dehydrogenase system.


Blood ◽  
2013 ◽  
Vol 122 (21) ◽  
pp. 2428-2428
Author(s):  
Satoshi Nishimura ◽  
Koji Eto ◽  
Ryozo Nagai

Abstract Blood platelets are generated in the bone marrow (BM) from their precursors, megakaryocytes (MK). Although we know that MKs produce platelets throughout life, precisely how platelets are produced in vivo remains uncertain, largely because of the rarity of MKs in the BM and the lack an adequate visualization technique. In the present study, we were able to visualize MK dynamics leading to platelet release in living animals at high resolution. To clearly understand the nature of thrombopoiesis in BM MKs, we optimized an in vivo imaging technique based on two-photon microscopy that enabled us to visualize living BM in CAG- enhanced green fluorescent protein (eGFP) mice. By visualizing living bone marrow in vivo, we observed that two modes (fragmentation and proplatelet formation) can be ongoing simultaneously in the same mouse. We observed that these two modes detectable by different morphological behavior can be ongoing simultaneously in the same BM of mouse, and are regulated by specific cytokines. Short proplatelets from megakaryocytes predominated at steady state, and more elongated proplatelets were accelerated by thrombopoietin (TPO) with responding to chronic platelet needs including recovery form BM transplantations. In contrast, acute platelet needs by blood loss, 5-FU administration or pritoneal acute inflammation increased cytoplasmic fragmentation following rapid ‘rupture’. Observed two modes are both dependent on tubulin reorganization on platelet biogenesis. In addition, platelet increase at acute phase is independent of proliferation by MK progenitors and this factor might exert apoptosis machinery on already reserved mature type of MKs. This humoral factor was identified by combination of in vitro screening systems and in vivo MK visualization analysis. Factor serum levels were reduced independently of the thrombopoietin level in human subjects with low platelet counts. It thus appears the cytokine balance dynamically regulates the mode of thrombopoiesis and the cellular programming of MKs. Thus, these novel factor may be a novel therapeutic target in thrombocytopenic situations, especially when associated with acute loss of platelets or when platelet transfusion is limited or unsuccessful. Disclosures: No relevant conflicts of interest to declare.


2003 ◽  
Vol 90 (11) ◽  
pp. 893-897 ◽  
Author(s):  
Remi Favier ◽  
Katayoun Jondeau ◽  
Patrice Boutard ◽  
Paul Grossfeld ◽  
Philippe Reinert ◽  
...  

SummaryParis-Trousseau syndrome (PTS) is an inherited disorder char-acterized by mild hemorragic tendency associated with 11q chromosome deletion. Here we report ten new patients (5 boys,5 girls) with complete clinical history, biological data, ultra-structural and molecular investigations. Thrombocytopenia is chronic in all the patients except two boys in whom it disappeared during the two first years of life. On Romanovsky stained peripheral blood smears, abnormal platelets with giant granules were detected in all the children and confirmed by electron microscopy (EM). On bone marrow smears, dysmega-karyopoiesis with many micromegakaryocytes was constantly observed. Abnormal alpha-granules were virtually absent from bone marrow and cultured megakaryocytes, while EM detected numerous images of granule fusion within blood platelets. Molecular analyses evidenced that the fli-1 gene is deleted in all the patients except one confirming the crucial role of the transcription factor FLI-1 in megakaryopoiesis. In summary, this study documents ten new cases of PTS with characteristic alpha-granule abnormalities, and shows the putative pathogenic role of fli-1 gene in the pathophysiology of this syndrome.


Blood ◽  
1990 ◽  
Vol 76 (8) ◽  
pp. 1473-1480
Author(s):  
AM Vannucchi ◽  
A Grossi ◽  
D Rafanelli ◽  
PR Ferrini

Murine recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) was injected in mice, and the effects on bone marrow, splenic megakaryocytes, megakaryocyte precursors (megakaryocyte colony-forming units [CFU-Meg]) were evaluated. In mice injected three times a day for 6 days with 12,000 to 120,000 U rGM-CSF, no significant modification of both platelet levels and mean platelet volume was observed, while there was a twofold increase in blood neutrophils. However, the rate of platelet production, as assessed by the measurement of 75selenomethionine incorporation into blood platelets, was On the contrary, administration of up to 384,000 U rGM-CSF two times a day for 2 days, as for a typical “thrombopoietin assay,” failed to modify platelet production. A significant dose-related increase in the number of splenic megakaryocytes occurred in mice receiving 60,000 to 120,000 U rGM-CSF, while a slight increase in the number of bone marrow megakaryocytes was observed in mice injected with 120,000 U rGM-CSF. The proportion of bone marrow megakaryocytes with a size less than 18 microns and greater than 35 microns resulted significantly higher in mice receiving rGM-CSF in comparison with controls; an increase in the percentage of splenic megakaryocytes greater than 35 microns was also observed. A statistically significant increase in the total spleen content of CFU-Meg was observed after administration of 90,000 and 120,000 U rGM-CSF three times a day for 6 days, while no effect on bone marrow CFU-Meg was recorded, irrespective of the dose delivered. Finally, 24 hours after a single intravenous injection of rGM-CSF, there was a significant increase in the proportion of CFU-Meg in S- phase, with the splenic progenitors being more sensitive than bone marrow-derived CFU-Meg. These data indicate that rGM-CSF has in vivo megakaryocyte stimulatory activity, and are consistent with previous in vitro observations. However, an effective stimulation of megakaryocytopoiesis in vivo, bringing about an increase in the levels of blood platelets, may require interaction of rGM-CSF with other cytokines.


Blood ◽  
2018 ◽  
Vol 132 (Supplement 1) ◽  
pp. SCI-23-SCI-23
Author(s):  
David Stegner ◽  
Judith van Eeuwijk ◽  
Maximilian G Gorelashvili ◽  
Oguzhan Angay ◽  
Mike Friedrich ◽  
...  

Abstract Blood platelets play key roles in hemostasis and thrombosis and are the second most abundant cell type in the circulation. Due to their short life span of only a few days, anuclear platelets are continuously replenished and thus provide a classic system to study hematopoiesis. In mammals, platelets are produced by megakaryocytes (MKs) that are predominantly residing in the bone marrow (BM). MKs originate from hematopoietic stem cells and are thought to migrate from an endosteal niche towards the vascular sinusoids during their maturation. Unfortunately, previous studies on megakaryopoiesis were often limited by 2D imaging and cutting artefacts when analyzing bone sections, potentially resulting in underestimation of MK-to-vessel contacts and MK volumes. We studied megakaryopoiesis by visualizing MKs in their 3D environment. To this end, murine bones were simultaneously stained for MKs and endothelial cells, fixed, chemically cleared and imaged by Light Sheet Fluorescence Microscopy (LSFM). Thus, we achieved 3D-reconstructions of the complete and intact bone with subcellular resolution. Through imaging of MKs in the intact BM, we show that MKs can be found within the entire BM, without a bias towards bone-distant regions. We developed and compared different image processing pipelines and simulation scenarios for precise identification of MKs in 3D light-sheet fluorescence microscopy of uncut murine bones. By combining in vivo two-photon microscopy and in situ LSFM with computational simulations, we reveal surprisingly slow MK migration, limited intervascular space, and a vessel-biased MK pool. To complement limited imaging approaches computational simulations represent an important, well-controllable tool. Typically, simulation studies use artificial meshes as templates to minimize the computational effort or due to the lack of experimental data. Unfortunately, such simplified artificial templates for MKs and the vasculature can bias simulations and lead to misinterpretations as we show here. Using the segmented cell and vessel objects of true 3D images can overcome those limitations providing a simulation framework that has the prerequisites to maximally reflect the physiological situation. Thus, imaging and simulations go hand in hand when the respective 3D cell and vessel objects perfectly serve as biological templates for advanced simulations. We demonstrate reliable whole-bone analysis in silico, and found that MKs influence neutrophil and HSC migration as biomechanical restrainers modulating cell mobility and extravasation. These data challenge the current thrombopoiesis model of MK migration and support a modified model, where MKs at sinusoids are replenished by sinusoidal precursors rather than cells from a distant periostic niche (1). Furthermore, we identify MKs as biomechanical restraints for bone marrow cell mobilization. As MKs themselves do not need to migrate to reach the vessel, therapies to increase MK numbers might be sufficient to raise platelet counts. (1) Stegner D, van Eeuwijk JMM, Angay O, Gorelashvili MG, Semeniak D, Pinnecker J, Schmithausen P, Meyer I, Friedrich M, Dütting S, Brede C, Beilhack A, Schulze H, Nieswandt B, Heinze KG. Thrombopoiesis is spatially regulated by the bone marrow vasculature, Nat Commun. 2017 8(1):127. Figure. Figure. Disclosures No relevant conflicts of interest to declare.


1980 ◽  
Vol 44 (02) ◽  
pp. 100-104 ◽  
Author(s):  
Anthon duP Heyns ◽  
Matthys G Lötter ◽  
Philip N Badenhorst ◽  
Otto van Reenen ◽  
Henry Pieters ◽  
...  

SummaryThe survival, tissue distribution and fate of 111Indium-oxine labelled autologous platelets was studied in four asplenic subjects with serial blood sampling, scintillation camera and computer-assisted imaging. Mean 111In-platelet recovery in the circulation was 89 ± 13% (± 1 SD). Platelet survival curves fitted a linear function best and was 238 ± 41 h. The shape of the survival curves of normal and asplenic subjects differed: in the asplenic subjects the curve was linear whereas that of normal subjects was significantly more curvilinear if analyzed by least squares computer fitting to a gamma function. Early hepatic 111In-activity was significant and transient and ascribed to the "collection injury". As labelled platelets disappeared from the circulation, 111Inactivity in the liver increased progressively and linearly to reach 42.5 ± 14.1 % of whole body activity at 240 h. Radioactivity also accumulated in the bone marrow, but could not be demonstrated in the vasculature of the lower limbs. These results would indicate that in asplenic subjects the major sites of destruction of senescent platelets are the liver and bone marrow.


Blood ◽  
1998 ◽  
Vol 92 (3) ◽  
pp. 756-764 ◽  
Author(s):  
Jian-Feng Wang ◽  
Zhong-Ying Liu ◽  
Jerome E. Groopman

Abstract CXCR4 is the receptor for the α-chemokine stromal cell-derived factor 1 (SDF-1) and has been shown to be expressed on a diversity of leukocytes. In this report, the expression of the CXCR4 receptor in cells of megakaryocytic lineage and the role of SDF-1 in megakaryocytopoiesis were investigated. Using flow cytometry in combination with reverse transcriptase-polymerase chain reaction (RT-PCR), we observed that bone marrow CD34+, CD61+ cells, blood platelets, and megakaryocytic leukemia cell lines all expressed the CXCR4 receptor. To examine the expression of the CXCR4 receptor on megakaryocyte progenitors (colony-forming units-megakaryocyte [CFU-Meg]), CXCR4-positive and -negative CD34+ populations were separated from bone marrow and cultured in a plasma clot culture system. A subpopulation of the CFU-Meg was found in the CXCR4-positive fraction. The functional significance of CXCR4 expression on cells of the megakaryocytic lineage was examined by studying the effects of SDF-1α on migration and proliferation of megakaryocyte progenitor cells in vitro. We found that SDF-1α potently induced megakaryocyte progenitor migration and significantly enhanced adhesion of mature marrow megakaryocytes to endothelium. No marked effects of SDF-1α alone or in combination with thrombopoietin and stem cell factor/kit ligand on megakaryocyte production in vitro were noted. These results demonstrate for the first time that the CXCR4 α-chemokine receptor is expressed on cells of the megakaryocytic lineage from progenitors to platelets and that its ligand SDF-1α may modulate several aspects of megakaryocytopoiesis. © 1998 by The American Society of Hematology.


Blood ◽  
2007 ◽  
Vol 110 (11) ◽  
pp. 2104-2104
Author(s):  
Julien Villeneuve ◽  
Anna Block ◽  
Caroline Le Bousse ◽  
Sebastien Lepreux ◽  
Jean-Max Pasquet ◽  
...  

Abstract Tissue inhibitors of matrix metalloproteinases (TIMPs) are a family of molecules that control extracellular matrix degradation through their ability to inactivate matrix metalloproteinases (MMPs). Non-MMP-dependent TIMP functions have also been recognized. Expression of TIMPs is an important way by which activated platelets may intervene in tissue remodeling and angiogenesis. We have studied the localization and release of TIMPs 1-4 from blood platelets, demonstrated their synthesis by megakaryocytes (MKs), and shown their normal presence in platelets of 2 patients with the Gray Platelet syndrome (GPS), an inherited disorder characterized by an absence of alpha-granules and marrow myelofibrosis. Bicolor confocal microscopy using paraformaldehyde-fixed and permeabilized resting platelets was first performed. A membrane glycoprotein (GPIbalpha) and the cytosolic protein beta-tubulin were used as controls. For each TIMP, colocalization with VWF or P-selectin, two alpha-granule proteins, was assessed using paired murine monoclonal or rabbit polyclonal antibodies detected using Alexa 458 or 488 (green) and Alexa 568 (red) conjugated species-specific secondary antibodies. The TIMPs were localized as fluorescent patches apparently distinct from the alpha-granules. These were often distributed at the platelet periphery and in proximity or associated with the membrane. TIMP-3 was also found to have an additional alpha-granule location. For the 2 patients with GPS, an expected sparse labeling of VWF was found in vestigial alpha-granules, but the peripheral expression and localization of the TIMPs remained unchanged and differed from that of residual P-selectin. Western blotting confirmed the presence of the TIMPs in resting platelets and thrombin activation resulted in a loss of TIMPs from platelet lysates with their simultaneous appearance in the platelet supernatants. Biosynthesis of the TIMPs by MKs was indicated by the presence of TIMP proteins in MKs derived in vitro from blood CD34+ progenitor cells of normal donors, in two megakaryocytic cell lines grown in serum-free conditions, and by the presence of mRNAs for each TIMP (RT-PCR). Thus MKs are a likely source of at least some of the TIMPs found in platelets. The TIMP localization is an illustration of the heterogeneity in the topological organization of the platelet secretome. Further colocalization studies showed that the TIMPs were organized individually and that they were not present as mixed hetero-oligomers. They were also located separately from MMPs (MMP-2, -9, ADAM10 and ADAM17 were tested) that co-localized at least in part in alpha-granules. An exception was the additional alpha-granule localization of TIMP-3 that may agree with its unique property in the TIMP family to associate with extracellulat matrix components. Finally, as TIMPs are key actors in tissue fibrosis, it is interesting to note that they were present in platelets from GPS patients, suggesting that they are not liberated during MK maturation in the bone marrow, an observation that would tend to exclude such a mechanism in the pathophysiology of bone marrow fibrosis, a condition associated with GPS.


Sign in / Sign up

Export Citation Format

Share Document